 |
|
Loss of Apolipoprotein E Receptor LR11 in Alzheimer Disease
Clemens R. Scherzer, MD;
Katrin Offe, MS;
Marla Gearing, PhD;
Howard D. Rees, PhD;
Guofu Fang, MS;
Craig J. Heilman, BS;
Chica Schaller, PhD;
Hideaki Bujo, MD, PhD;
Allan I. Levey, MD, PhD;
James J. Lah, MD, PhD
Arch Neurol. 2004;61:1200-1205.
Background Genetic, epidemiologic, and biochemical evidence suggests that apolipoprotein E, low-density lipoprotein receptors, and lipid metabolism play important roles in sporadic Alzheimer disease (AD).
Objective To identify novel candidate genes associated with sporadic AD.
Design We performed an unbiased microarray screen for genes differentially expressed in lymphoblasts of patients with sporadic AD and prioritized 1 gene product for further characterization in AD brain.
Setting Emory University, Atlanta, Ga.
Subjects Cell lines were used from 14 patients with AD and 9 normal human control subjects.
Results Six genes were differentially expressed in lymphoblasts of 2 independent groups of patients with probable AD and autopsy-proven AD. We hypothesized that 1 of the genes, termed low-density lipoprotein receptor relative with 11 binding repeats (LR11) (reduced 1.8- and 2.5-fold in AD lymphoblasts vs controls), might be associated with sporadic AD on the basis of its function as neuronal apolipoprotein E receptor. We found dramatic and consistent loss of immunocytochemical staining for LR11 in histologically normal-appearing neurons in AD brains. This reduction of LR11 protein was confirmed by quantitative Western blotting (P = .01).
Conclusions There is loss of the microarray-derived candidate, LR11, in neurons of AD brains. This study shows that microarray analysis of widely available lymphoblasts derived from patients with AD holds promise as a primary screen for candidate genes associated with AD.
Author Affiliations: Departments of Neurology (Drs Scherzer, Rees, Levey, and Lah and Messrs Fang and Heilman) and Pathology (Dr Gearing), Center for Neurodegenerative Disease (Ms Offe; Drs Gearing, Rees, Levey, and Lah; and Messrs Fang and Heilman), and Graduate Program in Neuroscience (Ms Offe and Dr Levey), Emory University, Atlanta, Ga; Zentrum für Molekulare Neurobiologie, Universität Hamburg, Hamburg, Germany (Dr Schaller); and Department of Genome Research and Clinical Application, Graduate School of Medicine, Chiba University, Chiba, Japan (Dr Bujo). Dr Scherzer is now with the Center for Neurologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Boston, Mass.
RELATED ARTICLE
Apolipoprotein E Receptor LR11: Intersections Between Neurodegeneration and Cholesterol Metabolism
Benjamin Wolozin
Arch Neurol. 2004;61(8):1178-1180.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Sortilin-related Receptor with A-type Repeats (SORLA) Affects the Amyloid Precursor Protein-dependent Stimulation of ERK Signaling and Adult Neurogenesis
Rohe et al.
J. Biol. Chem. 2008;283:14826-14834.
ABSTRACT
| FULL TEXT
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and A{beta} accumulation
Muhammad et al.
Proc. Natl. Acad. Sci. USA 2008;105:7327-7332.
ABSTRACT
| FULL TEXT
Retromer Sorting: A Pathogenic Pathway in Late-Onset Alzheimer Disease
Small
Arch Neurol 2008;65:323-328.
ABSTRACT
| FULL TEXT
Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention
Ma et al.
J. Neurosci. 2007;27:14299-14307.
ABSTRACT
| FULL TEXT
SorLA/LR11 Regulates Processing of Amyloid Precursor Protein via Interaction with Adaptors GGA and PACS-1
Schmidt et al.
J. Biol. Chem. 2007;282:32956-32964.
ABSTRACT
| FULL TEXT
Protection against beta-Amyloid-induced Apoptosis by Peptides Interacting with beta-Amyloid
Nelson and Alkon
J. Biol. Chem. 2007;282:31238-31249.
ABSTRACT
| FULL TEXT
Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA
Nielsen et al.
Mol. Cell. Biol. 2007;27:6842-6851.
ABSTRACT
| FULL TEXT
N-Linked Oligosaccharides on the Low Density Lipoprotein Receptor Homolog SorLA/LR11 Are Modified with Terminal GalNAc-4-SO4 in Kidney and Brain
Fiete et al.
J. Biol. Chem. 2007;282:1873-1881.
ABSTRACT
| FULL TEXT
Molecular markers of early Parkinson's disease based on gene expression in blood
Scherzer et al.
Proc. Natl. Acad. Sci. USA 2007;104:955-960.
ABSTRACT
| FULL TEXT
GGA1 Acts as a Spatial Switch Altering Amyloid Precursor Protein Trafficking and Processing
von Arnim et al.
J. Neurosci. 2006;26:9913-9922.
ABSTRACT
| FULL TEXT
SorLA Signaling by Regulated Intramembrane Proteolysis
Bohm et al.
J. Biol. Chem. 2006;281:14547-14553.
ABSTRACT
| FULL TEXT
sorLA: Sorting Out APP.
Shah and Yu
Mol. Interv. 2006;6:74-76.
ABSTRACT
| FULL TEXT
The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37
Rezgaoui et al.
J. Cell Sci. 2006;119:542-549.
ABSTRACT
| FULL TEXT
The Lipoprotein Receptor LR11 Regulates Amyloid beta Production and Amyloid Precursor Protein Traffic in Endosomal Compartments
Offe et al.
J. Neurosci. 2006;26:1596-1603.
ABSTRACT
| FULL TEXT
Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and beta-Secretase beta-Site APP-Cleaving Enzyme
Spoelgen et al.
J. Neurosci. 2006;26:418-428.
ABSTRACT
| FULL TEXT
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
Andersen et al.
Proc. Natl. Acad. Sci. USA 2005;102:13461-13466.
ABSTRACT
| FULL TEXT
Apolipoprotein E Receptor LR11: Intersections Between Neurodegeneration and Cholesterol Metabolism
Wolozin
Arch Neurol 2004;61:1178-1180.
FULL TEXT
|
